T1	Pharmacological_substance 0 10	Olanzapine
N1000 	Reference T1 MeSH:C076029	Olanzapine
T2	Disorder 19 31	parkinsonism
N1 	Reference T2 UMLS:C0242422	parkinsonism
T3	Pharmacological_substance 108 118	olanzapine
N1001 	Reference T3 MeSH:C076029	olanzapine
T4	Disorder 135 147	parkinsonism
N2 	Reference T4 UMLS:C0242422	parkinsonism
T5	Disorder 242 259	Parkinson disease
N3 	Reference T5 UMLS:C0030567	Parkinson disease
T6	Disorder 277 314	chronic obstructive pulmonary disease
N4 	Reference T6 UMLS:C0024117	chronic obstructive pulmonary disease
T7	Disorder 316 330	hyperlipidemia
N5 	Reference T7 UMLS:C0020473	hyperlipidemia
T8	Disorder 340 354	osteoarthritis
N6 	Reference T8 UMLS:C0029408	osteoarthritis
T9	Disorder 360 374	hypothyroidism
N7 	Reference T9 UMLS:C0020676	hypothyroidism
T10	Disorder 474 491	Parkinson disease
N8 	Reference T10 UMLS:C0030567	Parkinson disease
T11	Pharmacological_substance 556 565	carbidopa
N1002 	Reference T11 MeSH:D002230	carbidopa
T12	Pharmacological_substance 566 574	levodopa
N1003 	Reference T12 MeSH:D007980	levodopa
T13	Pharmacological_substance 684 694	olanzapine
N1004 	Reference T13 MeSH:C076029	olanzapine
T15	Disorder 711 727	bipolar disorder
N9 	Reference T15 UMLS:C0005586	bipolar disorder
T16	Disorder 926 943	Parkinson disease
N10 	Reference T16 UMLS:C0030567	Parkinson disease
T17	Pharmacological_substance 974 984	olanzapine
N1005 	Reference T17 MeSH:C076029	olanzapine
T18	Disorder 974 993	olanzapine toxicity
T19	Pharmacological_substance 1026 1035	Carbidopa
N1006 	Reference T19 MeSH:D002230	Carbidopa
T20	Pharmacological_substance 1036 1044	levodopa
N1007 	Reference T20 MeSH:D007980	levodopa
T21	Pharmacological_substance 1132 1142	olanzapine
N1008 	Reference T21 MeSH:C076029	olanzapine
T22	Pharmacological_substance 1156 1168	aripiprazole
N1009 	Reference T22 MeSH:D000068180	aripiprazole
T24	Disorder 1289 1301	bradykinesia
N11 	Reference T24 UMLS:C0233565	bradykinesia
T25	Disorder 1343 1366	extrapyramidal symptoms
N12 	Reference T25 UMLS:C0234133	extrapyramidal symptoms
T26	Disorder 1485 1497	parkinsonism
N13 	Reference T26 UMLS:C0242422	parkinsonism
T27	Disorder 1539 1560	adverse-drug-reaction
N14 	Reference T27 UMLS:C0041755	adverse-drug-reaction
T28	Pharmacological_substance 1718 1728	olanzapine
N1010 	Reference T28 MeSH:C076029	olanzapine
T29	Pharmacological_substance 1772 1782	olanzapine
N1011 	Reference T29 MeSH:C076029	olanzapine
T30	Disorder 1787 1803	bipolar disorder
N15 	Reference T30 UMLS:C0005586	bipolar disorder
T31	Disorder 1814 1826	parkinsonism
N16 	Reference T31 UMLS:C0242422	parkinsonism
T32	Subject 185 214	A 73-year-old Caucasian woman
T36	Subject 1730 1749	A 73-year-old woman
T38	Disorder 396 417	altered mental status
N17 	Reference T38 UMLS:C0278061	altered mental status
T39	Disorder 419 427	weakness
N18 	Reference T39 UMLS:C3714552	weakness
T40	Disorder 433 455	ambulatory dysfunction
N19 	Reference T40 UMLS:C0277785	ambulatory dysfunction
T42	Disorder 1275 1284	alertness
N20 	Reference T42 UMLS:C0239110	alertness
N21 	Reference T42 UMLS:C0239110	alertness
T43	Combination 565 566	-
T44	Combination 1035 1036	-
